Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income (loss)	$ 4,444	$ 1,602	$ 5,302
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expenses	714	718	673
Amortization of premiums and accretion of discounts associated with investments, net	(1,512)	(1,332)	(992)
(Gains) losses on investments and from sales of businesses, net	1,165	2,800	1,260
(Gains) losses on derivatives, net	2,716	3,259	4,150
(Income) loss from equity method investments, net of dividends or distributions	844	1,090	505
Interest credited to policyholder account balances	8,484	7,970	3,771
Universal life and investment-type product policy fees	(4,251)	(4,031)	(3,969)
Change in contractholder-directed equity securities and fair value option securities	(518)	(539)	1,671
Change in accrued investment income	(18)	(194)	(357)
Change in premiums, reinsurance and other receivables	460	(1,952)	299
Change in market risk benefits	(782)	(658)	(3,347)
Change in deferred policy acquisition costs and value of business acquired, net	(791)	(660)	(800)
Change in income tax	(484)	(1,177)	198
Change in other assets	0	(124)	138
Change in insurance-related liabilities and policy-related balances	4,079	4,637	3,937
Change in other liabilities	(580)	2,115	360
Other, net	628	197	245
Net cash provided by (used in) operating activities	14,598	13,721	13,044
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities available-for-sale	55,650	58,816	88,937
Sales, maturities and repayments of equity securities	158	1,018	873
Sales, maturities and repayments of mortgage loans	10,363	8,505	10,779
Sales, maturities and repayments of real estate and real estate joint ventures	753	143	1,096
Sales, maturities and repayments of other limited partnership interests	1,083	915	1,615
Sales, maturities and repayments of short-term investments	11,841	13,117	14,094
Purchases of fixed maturity securities available-for-sale	(65,667)	(63,460)	(82,956)
Purchases of equity securities	(112)	(73)	(1,368)
Purchases of mortgage loans	(8,950)	(8,795)	(16,403)
Purchases of real estate and real estate joint ventures	(1,033)	(1,057)	(1,208)
Purchases of other limited partnership interests	(1,401)	(1,670)	(2,674)
Purchases of short-term investments	(10,943)	(14,000)	(11,741)
Cash received in connection with freestanding derivatives	2,288	3,145	4,524
Cash paid in connection with freestanding derivatives	(3,981)	(5,662)	(7,793)
Sales of businesses	0	0	590
Purchases of investments in operating joint ventures	(40)	0	(240)
Net change in policy loans	106	34	104
Net change in other invested assets	(1,435)	(1,079)	(786)
Other, net	(173)	(143)	(63)
Net cash provided by (used in) investing activities	(11,493)	(10,246)	(2,620)
Cash flows from financing activities
Policyholder account balances - deposits	97,877	95,587	103,901
Policyholder account balances - withdrawals	(94,914)	(90,876)	(98,591)
Net change in payables for collateral under securities loaned and other transactions	(244)	(3,283)	(10,730)
Long-term debt issued	1,568	1,989	1,013
Long-term debt repaid	(1,792)	(1,035)	(85)
Collateral financing arrangement repaid	(161)	(79)	(50)
Derivatives with certain financing elements and other derivative-related transactions, net	(157)	(74)	(61)
Proceeds from mortgage loan secured financing	285	682	0
Repayments of mortgage loan secured financing	(882)	(845)	0
Treasury stock acquired in connection with share repurchases	(3,207)	(3,103)	(3,326)
Dividends on preferred stock	(200)	(198)	(185)
Dividends on common stock	(1,527)	(1,566)	(1,598)
Other, net	223	(139)	(236)
Net cash provided by (used in) financing activities	(3,131)	(2,940)	(9,948)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	(545)	(91)	(397)
Change in cash and cash equivalents	(571)	444	79
Cash and cash equivalents, including subsidiaries held-for-sale, beginning of year	20,639	20,195	20,116
Cash and cash equivalents, including subsidiaries held-for-sale, end of year	20,068	20,639	20,195
Cash and cash equivalents, subsidiaries held-for-sale, beginning of year	0	0	69
Cash and cash equivalents, subsidiaries held-for-sale, end of year	0	0	0
Cash and cash equivalents, beginning of year	20,639	20,195	20,047
Cash and cash equivalents, end of year	20,068	20,639	20,195
Supplemental disclosures of cash flow information
Net cash paid for Interest	1,037	989	905
Net cash paid (received) for Income tax	1,600	1,833	1,056
Non-cash transactions:
Fixed maturity securities available-for-sale disposed of in connection with a reinsurance transaction	0	8,984	0
Fixed maturity securities available-for-sale received in connection with pension risk transfer transactions	3,538	2,749	8,707
Mortgage loans disposed of in connection with a reinsurance transaction	0	196	0
Real estate and real estate joint ventures acquired in satisfaction of debt	359	32	495
Other invested assets received in connection with the sale of other limited partnership interests	375	0	0
Increase of real estate and real estate joint ventures	134	0	0
Increase of short-term debt	$ 113	$ 0	$ 0